Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

National Institutes of Health
Award USD 0–150K ≈ €0–€138K
Closing date 502 days left · Aug 11, 2027
Location Global
For Orgs

About this opportunity

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1) develop and/or adapt revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and/or 2) test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking. This R21 mechanism supports exploratory and developmental research that may lead to breakthrough discoveries in substance use disorder research.

Who can apply

Applicant Types

organization

Organization Types

nonprofit, for profit, academic, government, tribal

Project Locations

🇺🇸 United States

Region

United States

How to apply

Stages

  1. 1 single_stage

Required documents

research_proposal · budget

External listing — not managed by a verified Grantory funder

External Application

This opportunity requires you to apply directly on the funder's website.

Apply on External Site

AI-Extracted Data

This opportunity was automatically extracted from an external source using AI. Details such as amounts, closing dates, and eligibility may be incomplete or inaccurate.

Always verify on the official source